A carregar...

Treatment With Lenalidomide Modulates T-Cell Immunophenotype and Cytokine Production in Patients With Chronic Lymphocytic Leukemia

BACKGROUND: Lenalidomide, an immunomodulatory agent, has activity in lymphoproliferative disorders. The authors, therefore, evaluated its effects on T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia (CLL). METHODS: To study the immunomodulatory effects of l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Lee, Bang-Ning, Gao, Hui, Cohen, Evan N., Badoux, Xavier, Wierda, William G., Estrov, Zeev, Faderl, Stefan H., Keating, Michael J., Ferrajoli, Alessandra, Reuben, James M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349201/
https://ncbi.nlm.nih.gov/pubmed/21858802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25983
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!